Regulation of Antigen-Specific Immunoglobulin G Subclasses in Response to Conserved and Polymorphic Plasmodium falciparum Antigens in an In Vitro Model

ABSTRACT Cytophilic antibodies (Abs) play a critical role in protection against Plasmodium falciparum blood stages, yet little is known about the parameters regulating production of these Abs. We used an in vitro culture system to study the subclass distribution of antigen (Ag)-specific immunoglobulin G (IgG) produced by peripheral blood mononuclear cells (PBMCs) from individuals exposed to P. falciparum or unexposed individuals. PBMCs, cultivated with or without cytokines and exogenous CD40/CD40L signals, were stimulated with a crude parasite extract, recombinant vaccine candidates derived from conserved Ags (19-kDa C terminus of merozoite surface protein 1 [MSP119], R23, and PfEB200), or recombinant Ags derived from the polymorphic Ags MSP1 block 2 and MSP2. No P. falciparum-specific Ab production was detected in PBMCs from unexposed individuals. PBMCs from donors exposed frequently to P. falciparum infections produced multiple IgG subclasses when they were stimulated with the parasite extract but usually only one IgG subclass when they were stimulated with a recombinant Ag. Optimal Ab production required addition of interleukin-2 (IL-2) and IL-10 for all antigenic preparations. The IgG subclass distribution was both donor and Ag dependent and was only minimally influenced by the exogenous cytokine environment. In vitro IgG production and subclass distribution correlated with plasma Abs to some Ags (MSP119, R23, and MSP2) but not others (PfEB200 and the three MSP1 block 2-derived Ags). Data presented here suggest that intrinsic properties of the protein Ag itself play a major role in determining the subclass of the Ab response, which has important implications for rational design of vaccine delivery.

[1]  L. Marrama,et al.  Experimental IgG Antibody Production In vitro by Peripheral Blood and Tonsil Surface γ+ B Lymphocytes from Plasmodium falciparum‐Immune West Africans , 2001, Scandinavian journal of immunology.

[2]  H. Sartelet,et al.  In vitro production of immunoglobulins of various classes and subclasses by cord blood B cells in African neonates: modeling and assessment of determination. , 2001, Immunology letters.

[3]  J. Langhorne,et al.  Different Regions of the Malaria Merozoite Surface Protein 1 of Plasmodium chabaudi Elicit Distinct T-Cell and Antibody Isotype Responses , 2001, Infection and Immunity.

[4]  D. Kaslow,et al.  Short report: IgG1/IgG3 antibody responses to various analogs of recombinant ypfmsp119--a study in immune adults living in areas of Plasmodium falciparum transmission. , 2001, The American journal of tropical medicine and hygiene.

[5]  C. Rogier,et al.  Fixed, epitope‐specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP‐1 in humans living in a malaria‐endemic area , 2001, European journal of immunology.

[6]  K. Marsh,et al.  Differential Patterns of Human Immunoglobulin G Subclass Responses to Distinct Regions of a Single Protein, the Merozoite Surface Protein 1 of Plasmodium falciparum , 2001, Infection and Immunity.

[7]  A. Holder,et al.  Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119 , 2000, Infection and Immunity.

[8]  S. Franks The molecular characterization of Plasmodium falciparum infection and development of the humoral immune response in persistently infected Ghanaian infants , 2000 .

[9]  A. Spiegel,et al.  Flow cytometric analysis of IgG reactive to parasitized red blood cell membrane antigens in Plasmodium falciparum-immune individuals. , 1999, Acta tropica.

[10]  Holm,et al.  Immune responses to Plasmodium falciparum–merozoite surface protein 1 (MSP1) antigen, II. Induction of parasite‐specific immunoglobulin G in unsensitized human B cells after in vitro T‐cell priming with MSP119 , 1999, Immunology.

[11]  A. Spiegel,et al.  Immune responses to P. falciparum-MSP1 antigen: lack of correlation between antibody responses and the capacity of peripheral cellular immune effectors to respond to this antigen in vitro. , 1999, Immunology letters.

[12]  A. Holder,et al.  Different Plasmodium falciparum Recombinant MSP119 Antigens Differ in Their Capacities to Stimulate In Vitro Peripheral Blood T Lymphocytes in Individuals from Various Endemic Areas , 1999, Scandinavian journal of immunology.

[13]  B. Nahlen,et al.  Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites. , 1999, The American journal of tropical medicine and hygiene.

[14]  A. Spiegel,et al.  Imbalanced distribution of IgM and IgG antibodies against Plasmodium falciparum antigens and merozoite surface protein-1 (MSP1) in pregnancy. , 1998, Immunology letters.

[15]  B. Greenwood,et al.  IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. , 1998, The American journal of tropical medicine and hygiene.

[16]  A. Tall,et al.  Plasmodium falciparum- and merozoite surface protein 1-specific antibody isotype balance in immune Senegalese adults , 1997, Infection and immunity.

[17]  A. Holder,et al.  Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds , 1997, Infection and immunity.

[18]  A. Sabchareon,et al.  In vivo veritas: lessons from immunoglobulin-transfer experiments in malaria patients , 1997 .

[19]  A. Ferrante,et al.  Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass , 1997, Infection and immunity.

[20]  C. Rogier,et al.  Combating malaria morbidity and mortality by reducing transmission. , 1996, Parasitology today.

[21]  P. Deloron,et al.  IgG1 and IgG2 antibody responses to Plasmodium falciparum exoantigens correlate inversely and positively, respectively, to the number of malaria attacks. , 1996, FEMS immunology and medical microbiology.

[22]  C. Rogier,et al.  Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). , 1996, The American journal of tropical medicine and hygiene.

[23]  T. Nutman,et al.  The role of cytokines in human B-cell differentiation into immunoglobulin-secreting cells , 1996 .

[24]  E. Riley,et al.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass , 1995, Infection and immunity.

[25]  F. Perler,et al.  Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. , 1995, Journal of immunology.

[26]  F. Lunel,et al.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages , 1995, The Journal of Experimental Medicine.

[27]  A. Holder,et al.  Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum , 1995, Infection and immunity.

[28]  E. Bourreau,et al.  Induction of opsonizing antibodies after injection of recombinant Plasmodium falciparum vaccine candidate antigens in preimmune Saimiri sciureus monkeys , 1995, Infection and immunity.

[29]  C. Rogier,et al.  The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. , 1994, The American journal of tropical medicine and hygiene.

[30]  K. Mendis,et al.  Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus. , 1994, Molecular and biochemical parasitology.

[31]  D. Kaslow,et al.  Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae. , 1994, Molecular and biochemical parasitology.

[32]  C. Rogier,et al.  Malaria morbidity among children exposed to low seasonal transmission in Dakar, Senegal and its implications for malaria control in tropical Africa. , 1993, The American journal of tropical medicine and hygiene.

[33]  T. McCutchan,et al.  Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). , 1993, Molecular and biochemical parasitology.

[34]  O. Garraud,et al.  Squirrel monkey (Saimiri sciureus) B lymphocytes: secretion of IgG directed to Plasmodium falciparum antigens, by primed blood B lymphocytes restimulated in vitro with parasitized red blood cells. , 1993, Research in immunology.

[35]  G. Langsley,et al.  Plasmodium falciparum: characterization of gene R45 encoding a trophozoite antigen containing a central block of six amino acid repeats. , 1992, Experimental parasitology.

[36]  P. Druilhe,et al.  Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity , 1992, Infection and immunity.

[37]  A. Scherf,et al.  The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes. , 1992, Gene.

[38]  A. Sabchareon,et al.  Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes , 1990, The Journal of experimental medicine.

[39]  O. Garraud,et al.  Functional characterization of the antibody‐mediated protection against blood stages of Plasmodium falciparum in the monkey Saimiri sciureus , 1990, European journal of immunology.

[40]  H. Groux,et al.  Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. , 1990, Research in immunology.

[41]  P. Dubois,et al.  Protective antibodies against erythrocytic stages of Plasmodium falciparum in experimental infection of the squirrel monkey, Saimiri sciureus , 1982, Parasite immunology.

[42]  I. McGregor,et al.  Treatment of East African P. falciparum malaria with West African human γ-globulin , 1963 .